Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Miriam A. Barry"'
Publikováno v:
Frontiers in Oncology, Vol 10 (2021)
Externí odkaz:
https://doaj.org/article/1d32897e7c3248c084cb67029f53e93b
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Biologically based treatment planning is a broad term used to cover any instance in radiotherapy treatment planning where some form of biological input has been used. This is wide ranging, and the simpler forms (e.g., fractionation modification/optim
Externí odkaz:
https://doaj.org/article/be6c122dc00d4d83926f36c623a75792
Autor:
Joerg Lehmann, Mohammad Hussein, Miriam A. Barry, Shankar Siva, Alisha Moore, Michael Chu, Patricia Díez, David J. Eaton, Jeffrey Harwood, Peta Lonski, Elizabeth Claridge Mackonis, Carole Meehan, Rushil Patel, Xenia Ray, Maddison Shaw, Justin Shepherd, Gregory Smyth, Therese S. Standen, Brindha Subramanian, Peter B. Greer, Catharine H. Clark
Publikováno v:
Radiotherapy and Oncology. 171:121-128
The quality of radiotherapy delivery has been shown to significantly impact clinical outcomes including patient survival. To identify errors, institutions perform Patient Specific Quality Assurance (PSQA) assessing each individual radiotherapy plan p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bac1dd221a6a70455f27222cf3525c07
https://doi.org/10.1016/j.radonc.2022.04.019
https://doi.org/10.1016/j.radonc.2022.04.019
Publikováno v:
Frontiers in Oncology, Vol 10 (2020)
Frontiers in Oncology
Frontiers in Oncology
Biologically based treatment planning is a broad term used to cover any instance in radiotherapy treatment planning where some form of biological input has been used. This is wide ranging, and the simpler forms (e.g., fractionation modification/optim
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::03dbbd00d1f6250ee2326e4d73d9b8c2
https://surrey.eprints-hosting.org/858495/
https://surrey.eprints-hosting.org/858495/
Autor:
Miriam A. Barry, Giuseppe Schettino, Olivier Tillement, K Ricketts, Gary Royle, R Ahmad, Ben Russell, Quentin A. Pankhurst
Publikováno v:
Particle and Particle Systems Characterization
Particle and Particle Systems Characterization, Wiley-VCH Verlag, 2020, 37 (4), pp.1900411. ⟨10.1002/ppsc.201900411⟩
Particle and Particle Systems Characterization, Wiley-VCH Verlag, 2020, pp.1900411. ⟨10.1002/ppsc.201900411⟩
Particle & Particle Systems Characterization
Particle and Particle Systems Characterization, Wiley-VCH Verlag, 2020, 37 (4), pp.1900411. ⟨10.1002/ppsc.201900411⟩
Particle and Particle Systems Characterization, Wiley-VCH Verlag, 2020, pp.1900411. ⟨10.1002/ppsc.201900411⟩
Particle & Particle Systems Characterization
Materials with a high atomic number (Z) are shown to cause an increase in the level of cell kill by ionizing radiation when introduced into tumor cells. This study uses in vitro experiments to investigate the differences in radiosensitization between
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::39bd87a385c944a21ae16c04f60410f1
https://surrey.eprints-hosting.org/858497/
https://surrey.eprints-hosting.org/858497/
Autor:
Ileana Silvestre Patallo, Hugo Palmans, Amanda Tulk, Georgios Soultanidis, Miriam A. Barry, John Greenman, Victoria L. Green, Anna Subiel, Giuseppe Schettino, Christopher Cawthorne
Publikováno v:
Physics in medicine and biology. 65(8)
Despite well-established dosimetry in clinical radiotherapy, dose measurements in pre-clinical and radiobiology studies are frequently inadequate, thus undermining the reliability and reproducibility of published findings. The lack of suitable dosime
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::333815cb8c2fc1a8ac1916921eae3673
https://pubmed.ncbi.nlm.nih.gov/32109893
https://pubmed.ncbi.nlm.nih.gov/32109893
Autor:
Andrew Nisbet, C. South, Mohammad Hussein, Miriam A. Barry, Alexandra J. Stewart, Elizabeth J. Adams, T. Jordan
Publikováno v:
Radiotherapy and Oncology. 120:473-479
Purpose: The aim of this work was to determine whether a commercial knowledge-based treatment planning (KBP) module can efficiently produce IMRT and VMAT plans in the pelvic region (prostate & cervical cancer), and to assess sensitivity of plan quali
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::86d6a3aa6b82bc8145df8879f54fb1f2
https://doi.org/10.1016/j.radonc.2016.06.022
https://doi.org/10.1016/j.radonc.2016.06.022